Infectious complications of newer agents in the fight against diabetes.

Autor: Stover KR, Hugh E, Sherman JJ, Malinowski SS, Berdahl GJ, Riche DM
Jazyk: angličtina
Zdroj: The Nurse practitioner [Nurse Pract] 2020 Nov; Vol. 45 (11), pp. 17-24.
DOI: 10.1097/01.NPR.0000718508.65708.a1
Abstrakt: Infectious complications have been reported with antidiabetic medications. Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors have been associated with upper respiratory tract infections and urinary tract infections. Sodium-glucose cotransporter 2 inhibitors have been associated with lower limb amputations, urinary tract infections, genital mycotic infections, and Fournier gangrene.
Databáze: MEDLINE